Key result
Transcatheter aortic valve implantation with the SAPIEN 3 valve significantly improved left ventricular global longitudinal strain from -15.1 at baseline to -17.0 at 1 year (p<0.001).
Why the study?
Left ventricular mechanics are impaired in severe aortic stenosis, and the effect of TAVI with the SAPIEN 3 valve on LV function recovery assessed by global longitudinal strain was evaluated.
Does TAVI with a third-generation balloon-expandable valve improve left ventricular global longitudinal strain in patients with severe aortic stenosis?
Observational (n=276)
Yes
Does TAVI with a third-generation balloon-expandable valve improve left ventricular global longitudinal strain in patients with severe aortic stenosis?
Absolute Event Rate: -17% vs -15.1%
p-value: p=<0.001
TAVI with a third-generation balloon-expandable valve significantly improves left ventricular global longitudinal strain at discharge and 1 year, suggesting GLS is a more sensitive marker of LV recovery than LVEF.
BACKGROUND: Left ventricular (LV) mechanics are impaired in patients with severe aortic stenosis (AS); however, transcatheter aortic valve implantation (TAVI) may positively affect LV mechanics. Assessed herein is the performance of the SAPIEN 3 transcatheter heart valve (THV) and the effect of TAVI on LV function recovery, as assessed by global longitudinal strain (GLS). METHODS: A subset of patients from the SOURCE 3 registry (n = 276) from 16 European centers received SAPIEN 3 balloon-expandable THV. Echocardiography was performed at baseline, postprocedure, and at 1 year, including assessment of GLS using standard two-dimensional images, and was analyzed in a core laboratory. Paired analyses between baseline and discharge, baseline and at 1 year were conducted. RESULTS: Hemodynamic parameters were improved after TAVI and sustained to 1 year. At 1 year, the rate of moderate to severe paravalvular leaks (PVL), and moderate to severe mitral and tricuspid regurgitations were 1.8%, 1.7%, and 8.0%, respectively. The discharge GLS (-15.6 ± 5.1; p = 0.004; n = 149) improved significantly from baseline (-15.1 ± 4.8) following TAVI. This improvement was sustained at 1 year compared with baseline (-17.0 ± 4.6, p < 0.001; n = 100). Conversely, LV ejection fraction (LVEF) did not significantly change following TAVI (p = 0.47). CONCLUSIONS: Following TAVI with a third-generation THV, valve performances were good at 1 year with low PVL rate. The LV mechanics improved immediately after the procedure and were maintained at 1 year. These findings demonstrate the benefit of TAVI on LV mechanics, and suggests that GLS may be superior to LVEF in assessing this benefit. Clinicaltrial.gov number: NCT02698956.
No takes yet. Share an insight, caveat, or question.
Fernández-Santos et al. (2019) conducted an observational in Severe aortic stenosis (n=276). SAPIEN 3 transcatheter heart valve vs. Baseline was evaluated on Global longitudinal strain (GLS) at 1 year (p=<0.001). Transcatheter aortic valve implantation with the SAPIEN 3 valve significantly improved left ventricular global longitudinal strain from -15.1 at baseline to -17.0 at 1 year (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: